UNTERSUCHUNG ZUR BIOAQUIVALENZ VON METOCLOPRAMID IN ZWEI TABLETTENFORMULIERUNGEN
Research output: Contribution to journal › Research article › Contributed › peer-review
Contributors
Abstract
An investigation on the bioavailability of a tablet with 10 mg metoclopramide-HCl (CAS 363-62-5) Cerucal® was performed in a two-way cross-over study with 12 volunteers. Metoclopramide was determined in serum by HPLC. The relative bioavailability (mean and nonparametric 95% confidence interval) with respect to a reference preparation was 0.95 (95% CI 0.88-1.02) for AUC and 0.92 (95% CI 0.79-1.07) for C(max). A positive decision for bioequivalence was derived from the usual confidence intervals for both parameters. The t(max)-values did not differ significantly. Statistical evaluation of all parameters revealed bioequivalence between the two preparations.
Translated title of the contribution | Bioequivalence of metoclopramide in two tablet formulations |
---|
Details
Original language | German |
---|---|
Pages (from-to) | 304-306 |
Number of pages | 3 |
Journal | Arzneimittel-Forschung/Drug Research |
Volume | 45 |
Issue number | 3 |
Publication status | Published - 1995 |
Peer-reviewed | Yes |
External IDs
PubMed | 7741790 |
---|---|
ORCID | /0000-0003-1526-997X/work/142247283 |
Keywords
ASJC Scopus subject areas
Keywords
- CAS 363-62-5, Cerucal®, bioequivalence, clinical studies, gastrointestinal drugs, metoclopramide